Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Basic Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Abiogen Pharma s.r.l.
Patents Assigned to Abiogen Pharma s.r.l.
Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II
Patent number:
5922769
Abstract:
Non-insulin dependent diabetes mellitus in cases of secondary failure is treated with a combination of glibenclamide and metformin.
Type:
Grant
Filed:
May 13, 1998
Date of Patent:
July 13, 1999
Assignee:
Abiogen Pharma s.r.l.
Inventors:
Giulio Barelli, Massimo De Regis